Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare, Leqembi and Alzheimer's
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be unused and discarded, according to a new study published in JAMA Internal Medicine. That could result in $133 million to $336 million in waste per year for Medicare, the study found.
New Vial Size Could Save US Medicare Millions on Alzheimer's Breakthrough Drug Leqembi
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or lecanemab by simply introducing a new vial size that would reduce the amount of unused medication thrown away.
Big vials of Alzheimer's drug could cost Medicare $336M
Medicare could be throwing away as much as $336 million worth of a costly Alzheimer's drug each year because the size of vials is too big, UCLA researchers estimate. Why it matters: The findings, published Monday in JAMA Internal Medicine,
pharmaphorum
21h
Australia joins EU in turning down Alzheimer's drug Leqembi
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...
3d
on MSN
Changing Alzheimer's drug vial size might save big money for Medicare
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
2d
on MSN
Alzheimer's: Simple Drug Change Could Save Medicare Hundreds of Millions
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
ENDPOINTS NEWS
15h
Eisai to ask Australia to reconsider rejection of Alzheimer's drug Leqembi
Australia’s regulatory agency rejected Biogen and Eisai’s Alzheimer’s drug Leqembi, noting that the drug's efficacy doesn't ...
U.S. News & World Report
3d
Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare
Medicare patients can be prescribed
Leqembi
if they’ve been diagnosed with mild cognitive impairment or mild
Alzheimer
’s disease and their doctor agrees to participating in ongoing data ...
KTXS
13d
"I wasn't able to just give up," Abilene man finds hope with Alzheimer's treatment
While Alzheimer’s can’t be reversed, Leqembi has proven that it can slow down the progression of the disease.
Armed robbery in Revesby
2d
TGA's Decision To Not Register Lecanemab
The Therapeutic Goods Administration (TGA) has made the decision not to register lecanemab (LEQEMBI) for the treatment of ...
News Medical on MSN
2d
Alzheimer’s Disease Can Damage The Brain In Two Stages: Study
A recent study supported by the National Institutes of Health (NIH) and published in Nature Neuroscience found that Alzheimer ...
1d
Experts label TGA’s decision to not register Alzheimer’s drug ‘extremely disappointing’
A much-anticipated drug that holds the promise of delaying symptoms of Alzheimer’s disease will not be available in Australia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback